Nortriptilina Tecnifar (Nortriptyline)

Nortriptyline, the active ingredient in Nortriptilina Tecnifar, is a tricyclic antidepressant presented as an oral tablet for oral use. It works by modulating neurotransmitter activity and is prescribed for major depressive disorder, neuropathic pain and tension‑type headache in adult patients.

GNH USA supplies Nortriptilina Tecnifar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution. The product meets all EU marketing authorisation requirements and is manufactured under GMP conditions.

Nortriptyline is indicated for several conditions that involve mood regulation and pain pathways.

- Major depressive disorder: alleviates depressive symptoms and improves mood in adults. - Neuropathic pain: reduces pain intensity associated with peripheral nerve damage. - Chronic tension‑type headache: decreases frequency and severity of tension‑type headache episodes.

Nortriptilina Tecnifar may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Dry mouth: reduced salivation leading to thirst. - Constipation: slowed gastrointestinal motility. - Drowsiness or sedation: increased sleepiness. - Weight gain: increased appetite and body weight.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm, especially in overdose. - Seizures: risk of convulsions, particularly in predisposed patients. - Severe hypotension: marked drop in blood pressure causing dizziness.

Before initiating therapy, clinicians should consider several safety aspects.

- Cardiovascular assessment: evaluate heart rhythm and conduction before starting treatment. - CNS depression: monitor for excessive sedation, especially when combined with other CNS depressants. - Glaucoma risk: avoid in patients with narrow‑angle glaucoma due to anticholinergic effects. - Elderly patients: start with lower doses and monitor for confusion or falls. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Nortriptilina Tecnafar can interact with other medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - MAO inhibitors: concurrent use can cause hypertensive crisis or serotonin syndrome. - SSRIs or SNRIs: combined therapy increases risk of serotonin syndrome. - Anticholinergic drugs: additive anticholinergic burden may worsen dry mouth, constipation, and urinary retention.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may raise nortriptyline plasma levels. - CNS depressants (e.g., benzodiazepines, alcohol): enhance sedative effects. - Diuretics: may potentiate orthostatic hypotension.